A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)

PHASE4CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

May 31, 2007

Conditions
Diabetic Neuropathy, Painful
Interventions
DRUG

pregabalin

Trial Locations (35)

Unknown

Pfizer Investigational Site, Buenos Aires

Pfizer Investigational Site, Belo Horizonte

Pfizer Investigational Site, Niterói

Pfizer Investigational Site, Valparaíso

Pfizer Investigational Site, Providencia

Pfizer Investigational Site, Medellín

Pfizer Investigational Site, Bogotá

Pfizer Investigational Site, Quito

Pfizer Investigational Site, Jakarta Pusat

Pfizer Investigational Site, Surabaya

Pfizer Investigational Site, Amman

Pfizer Investigational Site, Beirut

Pfizer Investigational Site, Kuala Lumpur

Pfizer Investigational Site, Monterrey

Pfizer Investigational Site, Mexico City

Pfizer Investigational Site, San Luis Potosí City

Pfizer Investigational Site, España

Pfizer Investigational Site, Quezon City

Pfizer Investigational Site, Riyadh

Pfizer Investigational Site, Singapore

Pfizer Investigational Site, Pusan

Pfizer Investigational Site, Seoul

Pfizer Investigational Site, Gueishan Shiang

Pfizer Investigational Site, Taipei

Pfizer Investigational Site, Khet Rajathevee

Pfizer Investigational Site, Muang

Pfizer Investigational Site, Çapa

Pfizer Investigational Site, Ankara

Pfizer Investigational Site, Istanbul

Pfizer Investigational Site, Izmir

Pfizer Investigational Site, Mersin

Pfizer Investigational Site, Abu Dhabi

Pfizer Investigational Site, El Hatillo Municipality

Pfizer Investigational Site, Caracas

Pfizer Investigational Site

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00156078 - A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN) | Biotech Hunter | Biotech Hunter